nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
All about COVID-19 in brief
|
Naserghandi, A. |
|
|
35 |
C |
p. |
artikel |
2 |
Anaerococcus marasmi sp. nov., a new bacterium isolated from human gut microbiota
|
Tall, M.L. |
|
|
35 |
C |
p. |
artikel |
3 |
A short review on antibody therapy for COVID-19
|
Venkat Kumar, G. |
|
|
35 |
C |
p. |
artikel |
4 |
Consideration of dornase alfa for the treatment of severe COVID-19 acute respiratory distress syndrome
|
Earhart, A.P. |
|
|
35 |
C |
p. |
artikel |
5 |
COVID-19 and intracerebral haemorrhage: causative or coincidental?
|
Sharifi-Razavi, A. |
|
|
35 |
C |
p. |
artikel |
6 |
COVID-19 outbreak: current scenario of Pakistan
|
Waris, A. |
|
|
35 |
C |
p. |
artikel |
7 |
Epidemic of venereal treponematosis in wild monkeys: a paradigm for syphilis origin
|
Mediannikov, O. |
|
|
35 |
C |
p. |
artikel |
8 |
Epidemiology, genome, and clinical features of the pandemic SARS-CoV-2: a recent view
|
Abduljalil, J.M. |
|
|
35 |
C |
p. |
artikel |
9 |
Evidence of an environmental reservoir for emergent Mycobacterium colombiense
|
Andreani, J. |
|
|
35 |
C |
p. |
artikel |
10 |
Fatal pulmonary infection related to Nocardiopsis dassonvillei in a patient with chronic obstructive pulmonary disease
|
Scussel, R. |
|
|
35 |
C |
p. |
artikel |
11 |
High-resolution melt curve analysis for rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a single-centre study in Iran
|
Arefzadeh, S. |
|
|
35 |
C |
p. |
artikel |
12 |
Importation of dengue, Zika and chikungunya infections in Europe: the current situation in Greece
|
Emmanouil, M. |
|
|
35 |
C |
p. |
artikel |
13 |
Isolation of a novel intertypic recombinant human mastadenovirus B2 from two unrelated bone marrow transplant recipients
|
Kajon, A.E. |
|
|
35 |
C |
p. |
artikel |
14 |
Massilistercora timonensis gen. nov., sp. nov., a new bacterium isolated from the human microbiota
|
Tall, M.L. |
|
|
35 |
C |
p. |
artikel |
15 |
Mutated COVID-19 may foretell a great risk for mankind in the future
|
Dawood, A.A. |
|
|
35 |
C |
p. |
artikel |
16 |
NMNI editorial report, 2019
|
Grine, G. |
|
|
35 |
C |
p. |
artikel |
17 |
Non-contiguous finished genome sequence and description of Bartonella saheliensis sp. nov. from the blood of Gerbilliscus gambianus from Senegal
|
Dahmana, H. |
|
|
35 |
C |
p. |
artikel |
18 |
Novel coronavirus disease (COVID-19): a pandemic (epidemiology, pathogenesis and potential therapeutics)
|
Hamid, Saima |
|
|
35 |
C |
p. |
artikel |
19 |
Pacemaker-associated infection caused by ST81/SCCmec IV methicillin-resistant, vancomycin-intermediate Staphylococcus aureus in Japan
|
Sakurada, M. |
|
|
35 |
C |
p. |
artikel |
20 |
Peripherally inserted central catheters: a hidden emerging cause of infection outbreaks
|
Durand, G.A. |
|
|
35 |
C |
p. |
artikel |
21 |
Potential use of hydroxychloroquine, ivermectin and azithromycin drugs in fighting COVID-19: trends, scope and relevance
|
Choudhary, R. |
|
|
35 |
C |
p. |
artikel |
22 |
Prevalence, molecular characteristics and antimicrobial susceptibility patterns of MRSA in hospitalized and nonhospitalized patients in Barbados
|
Gittens-St Hilaire, M.V. |
|
|
35 |
C |
p. |
artikel |
23 |
Prevalence of metallo-β-lactamase–producing Pseudomonas aeruginosa isolated from diabetic foot infections in Iraq
|
Alkhudhairy, M.K. |
|
|
35 |
C |
p. |
artikel |
24 |
Preventive strategies used by GI physicians during the COVID-19 pandemic
|
Hormati, A. |
|
|
35 |
C |
p. |
artikel |
25 |
Review on the global epidemiological situation and the efficacy of chloroquine and hydroxychloroquine for the treatment of COVID-19
|
Saqrane, S. |
|
|
35 |
C |
p. |
artikel |
26 |
Segniliparus rugosus from the sputum of a child with cystic fibrosis in Ecuador: challenges in bacterial identification
|
Zurita, J. |
|
|
35 |
C |
p. |
artikel |
27 |
Unrecognized HIV infection in asymptomatic volunteer blood donors at district Peshawar, Khyber Pakhtunkhwa, Pakistan
|
Haq, I. |
|
|
35 |
C |
p. |
artikel |